REFERENCES
- Patrinos GP, Antonarakis SE. Human hemoglobin. In: Speicher M, Antonarakis SE, Motulsky A, Eds. Human Genetics: Problems and Approaches, 4th ed. Heidelberg: Springer Verlag. 2010:366–401.
- Rund D, Rachmilewitz E. β-Thalassemia. N Eng J Med. 2005; 353(11):1135–1146.
- Muncie HL Jr, Campbell J. α And β thalassemia. Am Fam Physician. 2009;80(4):339–44.
- Borgna-Pignatti C. Modern treatment of thalassaemia intermedia. Br J Haematol. 2007;138(3):291–304.
- Singer ST, Kuypers FA, Olivieri NF, Single and combination drug therapy for fetal hemoglobin augmentation in Hemoglobin E-β0-thalassemia: considerations for treatment. Ann NY Acad Sci. 2005;1054; 250–256.
- Patrinos GP, Grosveld FG. Pharmacogenomics and therapeutics of hemoglobinopathies. Hemoglobin. 2008;32(1–2):229–236.
- Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004;32(Database issue):D537-D541 (http://globin.bx.cse.psu.edu/hbvar).
- Hardison RC, Chui DHK, Giardine B, et al. Hb Var: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat. 2002;19(3):225–233 (http://globin.bx.cse.psu.edu/hbvar).
- Cao A, Galanello R, Rosatelli C. Genotype-phenotype correlations in β-thalassaemias. Blood Rev. 1994;8:1–12.
- Papachatzopoulou A, Kourakli A, Makropoulou P, Genotypic heterogeneity and correlation to intergenic haplotype within high Hb F β-thalassemia intermedia. Eur J Haematol. 2006;76(4):322–330.
- Boussiou M, Karababa P, Sinopoulou K, Tsaftaridis P, Plata E, Loutradi-Anagnostou A. The molecular heterogeneity of β-thalassemia in Greece. Blood Cells Mol Dis. 2008;40(3):317–319.
- Kattamis C, Hu H, Cheng G, Molecular characterization of β-thalassaemia in 174 Greek patients with thalassaemia major. Br J Haematol. 1990;74(3):342–346.
- Kollia P, Karababa PH, Sinopoulou K, β-Thalassaemia mutations and the underlying β gene cluster haplotypes in the Greek population. Gene Geogr. 1992;6(1–2):59–70.
- Patrinos GP, van Baal S, Petersen MB, Papadakis MN. Hellenic National Mutation database: a prototype database for mutations leading to inherited disorders in the Hellenic population. Hum Mutat. 2005;25(4):327–333.
- Samara M, Chiotoglou I, Kalamaras A, Large scale population genetic analysis for haemoglominopathies reveals different mutation spectra in central Greece compared to the rest of the country. Am J Hematol. 2007;82(7):634–636.
- Georgiou I, Makis A, Chaidos A, Distribution and frequency of β-thalassemia mutations in northwestern and central Greece. Eur J Haematol. 2003;70(2):75–78.
- Vrettou C, Traeger-Synodinos J, Tzetis M, Palmer G, Sofocleous C, Kanavakis E. Real-time PCR for single genotyping in sickle cell and thalassemia syndroms as a rapid, accurate, reliable, and widely applicable protocol for preimplantation genetic diagnosis. Hum Mutat. 2004;23(5):513–521.
- Tatusova TA, Madden TL. BLAST 2 Sequences, a new tool for comparing protein and nucleotide sequences. FEMS Microbiol Lett. 1999;174(2):247–250.
- Papadakis M, Papapanagiotou E, Loutradi-Anagnostou A. Scanning method to identify the molecular heterogeneity of δ-globin gene especially in δ-thalassemias: detection of three novel substitutions in the promoter region of the gene. Hum Mutat. 1997;9(5):465–472.
- Zlotogora J, van Baal S, Patrinos GP. Documatation of inherited disorders and mutation frequencies in the different religious communities in Israel in the Israeli National Genetic Database. Hum Mutat. 2007;28(10):944–949.
- Tadmouri GO, Tuzmen S, Ozcelik H. Molecular and population genetic analysis of β-thalassemia in Turkey. Am J Hematol. 1998;57(3):215–220.
- Viprakasit V, Gibbons RJ, Broughton BC, Mutations in the general transcription factor TFIIH result in β-thalassaemia in individuals with trichothiodystrophy. Hum Mol Genet. 2001;10(24):2797–2802.